Vioba Pharmaceuticals is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

VISION, MISSION AND STRATEGIC FOUNDATIONS

The world’s leading company in developing and manufacturing peptides and oligonucleotides. The most trusted and reliable partner for pharmaceutical and biotech companies. A key contribution to the discovery and development of innovative medicines that help to treat, and even cure, patients for a variety of diseases. A great place to work for team-minded people who want to make an impact. That is our vision at Vioba Pharmaceuticals.

Our mission is to make this claim reality: We aim to be the world-leading specialist in peptides and oligonucleotides with an unmatched market position, sales north of CHF one billion and strong profitability for independence and to attract and develop the most engaged and skilled workforce in our field.

Vioba Pharmaceuticals has identified five strategic foundations for this journey and set corresponding goals for the coming years.
At Vioba Pharmaceuticals, we stand for long-term partnerships and excellent service. Innovation and technological leadership are as important to us as highest quality and operational excellence. Our passionate and dedicated employees, along with our unique corporate culture, are the foundation of our success. Together, these elements provide a direction for how we want to grow, develop profitably, invest and become ever more sustainable in our business and underline our ambition for market leadership and independence. We break these down with clear priorities every year. In particular, the combination of our five strategic foundations sets us apart from the competition.